Skip to main content
SleepCited

Taurine Nighttime Pain-Related Sleep Disruption

B

Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dtaurine\u0026condition\u003Dnighttime\u002Dpain\u002Dsleep'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.

Key Study Findings

Controlled Clinical Trial n=32 12 weeks Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None vs: Standard care alone Outcome: Itch and insomnia improvement in atopic dermatitis 効果: None 0.0449 (itch), 0.0089 (insomni

対象集団: Patients with atopic dermatitis and mild-moderate negative emotions

Other
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Dose: None vs: None Outcome: None 効果: None p < .05

対象集団: Insomnia patients

Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None vs: None Outcome: Pain outcomes 効果: None None

対象集団: Insomnia patients

Observational Study
[Energy drink consumption patterns and its adverse effects on adolescent health.].
Dose: None vs: None Outcome: Energy drink consumption and adverse effects 効果: None None

対象集団: Adolescents

Other
[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …
Dose: None vs: None Outcome: rat model of cardiorenal insomnia from in vitro … 効果: None None

対象集団: None

Review
Assessment and treatment of insomnia in adult patients with alcohol use disorders.
Dose: None vs: None Outcome: None 効果: None None

対象集団: insomnia patients

Key Statistics

9

研究数

32

参加者数

Mixed

B

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

sleep:
500-2,000 mg, 1 hour before bed

上限量: 3,000 mg/day considered safe in clinical studies

研究で検討された用量

用量 期間 効果 N
None 12 weeks Positive 32
None -- Neutral --
None -- Neutral --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --

推奨摂取タイミング: 1 hour before bed

Safety & Side Effects

報告されている副作用

  • Generally well tolerated
  • Mild GI discomfort at high doses
  • Drowsiness (desired for sleep use)

既知の相互作用

  • Lithium — taurine may alter lithium excretion
  • Antihypertensives — may have additive blood pressure lowering effects
  • CNS depressants — potential additive sedative effects

耐容上限摂取量: 3,000 mg/day considered safe in clinical studies

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Taurine help with Nighttime Pain-Related Sleep Disruption?
Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support Nighttime Pain-Related Sleep Disruption management. Our evidence grade is B (Good Evidence).
How much Taurine should I take for Nighttime Pain-Related Sleep Disruption?
Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Taurine?
Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Taurine and Nighttime Pain-Related Sleep Disruption?
We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

Related Evidence

Taurine 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。